These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3095160)

  • 1. Buccal nitroglycerin in congestive cardiac failure: a multicentre study.
    Sanghera SS; Goldberg AA; Parsons DG
    J Int Med Res; 1986; 14(5):274-8. PubMed ID: 3095160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buccal nitroglycerin in elderly patients with congestive cardiac failure.
    Sanghera SS; Goldberg AA; Parsons DG
    Practitioner; 1985 Dec; 229(1410):1054-5. PubMed ID: 3937151
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effects of nitroglycerin on refractory congestive heart failure by intravenous infusion].
    Ma S
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Jun; 20(3):160-2, 195. PubMed ID: 1289026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of sustained action buccal nitroglycerin in severe congestive heart failure.
    Lahiri A; Crawley JC; Sonecha TN; Raftery EB
    Int J Cardiol; 1984 Jan; 5(1):39-48. PubMed ID: 6420352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained salutary effects of oral controlled-release nitroglycerin on ventricular function in congestive heart failure.
    Amsterdam EA; Awan NA; DeMaria AN; Miller RR; Williams DO; Mason DT
    Clin Cardiol; 1979 Feb; 2(1):19-25. PubMed ID: 115631
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nitroglycerin by transdermal route in chronic congestive heart failure].
    Schiavoni G; Mazzari M; Mongiardo R; Frustaci A; Rebuzzi AG; Pennestrì F; Amico C; Bosimini E; Albanese S; Manzoli U
    Cardiologia; 1985 Dec; 30(12):1145-51. PubMed ID: 3939565
    [No Abstract]   [Full Text] [Related]  

  • 7. Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual.
    Cagin NA; Benda R; Somberg J; Levitt B
    N Y State J Med; 1978 May; 78(6):888-9. PubMed ID: 418364
    [No Abstract]   [Full Text] [Related]  

  • 8. [New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
    Bussmann WD
    Med Klin; 1975 Oct; 70(42):1697-1706. PubMed ID: 810653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haemodynamic effects after application of nitroglycerin sublingually or as ointment in patients with left ventricular heart failure (author's transl)].
    Magometschnigg D; Bonelli J; Gassner A; Lenzhofer R; Kleinberger G; Pall H; Pichler M
    Wien Klin Wochenschr; 1980 Jan; 92(1):24-6. PubMed ID: 6769256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buccal nitroglycerin tablets in heart failure.
    Lahiri A; Piero Carboni G; Raftery EB
    Ann Intern Med; 1986 Jul; 105(1):141. PubMed ID: 3087255
    [No Abstract]   [Full Text] [Related]  

  • 12. New nitroglycerin formulations: transdermal and transmucosal nitroglycerin.
    Abrams J
    Z Kardiol; 1985; 74 Suppl 4():10-5. PubMed ID: 3938113
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
    Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
    Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
    [No Abstract]   [Full Text] [Related]  

  • 14. Buccal nitroglycerin in routine clinical practice. A multicentre study.
    Parsons DG; Goldberg AA; Edgar P; Sanghera S
    Br J Clin Pract; 1983 Sep; 37(9):295-8. PubMed ID: 6414502
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter studies of 2% nitroglycerin ointment in patients with heart failure.
    Kawai C; Kambara H; Nakano T; Hirota Y; Saito M; Kagoshima T; Nobuyoshi M; Tsuruha Y
    Clin Ther; 1984; 6(5):677-88. PubMed ID: 6434184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained hemodynamic effects with therapeutic doses of intravenous nitroglycerin in congestive heart failure.
    Natarajan D; Khurana TR; Karhade V; Nigam PD
    Am J Cardiol; 1988 Aug; 62(4):319-21. PubMed ID: 3135741
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of the replacement of intravenous trinitrin by oral trinitrin in the acute phase of myocardial infarction complicated by regressive left ventricular insufficiency].
    Gibelin P; Ferrari E; Tiger F; Morand P
    Ann Cardiol Angeiol (Paris); 1991 Sep; 40(7):447-51. PubMed ID: 1952777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of cardiac output by afterload reduction in patients with severe congestive heart failure using nitroglycerin discs. A double-blind placebo-controlled haemodynamic study.
    Heikkilä J; Pellinen TJ; Blake P; McAllister A; Yardley J
    Ann Clin Res; 1987; 19(3):203-7. PubMed ID: 3118755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of nitroglycerin in the treatment of acute heart failure and cardiogenic shock in patients with myocardial infarction.
    Belskii NE; Pilipenko VA; Roshchin SI; Shira AI; Gilmar IS
    Cor Vasa; 1987; 29(2):89-97. PubMed ID: 3109805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and reversal of nitrate tolerance in patients with congestive heart failure.
    Packer M; Lee WH; Kessler PD; Gottlieb SS; Medina N; Yushak M
    N Engl J Med; 1987 Sep; 317(13):799-804. PubMed ID: 3114637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.